Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.5 appears in the study's revision history. The previous entry v3.6.4 is removed from the updated history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.6.4 is added to the history. The previous v3.6.3 entry is removed, reflecting an update to the record's documentation.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry, v3.6.3, was added to the study record history and the previous revision v3.6.2 was removed, reflecting an update to the page's revision log.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the Record History, replacing the previous 'Revision: v3.6.0'. This indicates a software update to the study record history page.SummaryDifference0.1%

- Check58 days agoChange DetectedOn 2026-06-08, the study status was updated to 'No longer looking for participants', indicating recruitment for this trial has closed. This change affects how users interpret the study's current availability and eligibility.SummaryDifference1%

- Check65 days agoChange DetectedA new revision tag 'Revision: v3.5.5' was added to the study record history, and the previous 'Revision: v3.5.4' entry was removed, updating the record history to reflect the latest version.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.